Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2909 studies found for:    Open Studies | "Brain Diseases"
Show Display Options
Rank Status Study
21 Recruiting The Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Placebo;   Drug: Rifaximin
22 Unknown  Safety Study Using Transcranial MR Guided Focused Ultrasound in the Treatment of Neuropathic Pain
Condition: Functional Brain Disorders /Neuropathic Pain
Intervention: Device: ExAblate 4000 focused ultrasound brain intervention
23 Recruiting Study of Selected X-Linked Disorders: Aicardi Syndrome
Conditions: Aicardi Syndrome;   Brain Disorders
Intervention:
24 Recruiting Study on Moebius Syndrome and Other Congenital Facial Weakness Disorders
Conditions: Brain Disorders;   Birth Defects;   Craniofacial Differences
Intervention:
25 Recruiting Brain Development Research Program
Conditions: Brain Disorders;   Aicardi Syndrome
Intervention:
26 Recruiting Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: L-ornithine L-aspartate;   Drug: Rifaximin;   Drug: Placebo
27 Recruiting The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin
28 Unknown  Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage
Conditions: Hepatocerebral Encephalopathy;   Portal-Systemic Encephalopathy;   Encephalopathy, Hepatic;   Encephalopathy, Hepatocerebral
Interventions: Drug: Lactulose;   Drug: Placebo
29 Recruiting L-ornithine L-aspartate in Overt Hepatic Encephalopathy
Conditions: Cirrhosis of Liver;   Hepatic Encephalopathy
Interventions: Drug: L-ornithine L-aspartate;   Drug: Placebo
30 Unknown  Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Probiotics(VSL#3)
31 Unknown  Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Intervention: Drug: Lactulose
32 Not yet recruiting Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate
Conditions: Hepatic Encephalopathy;   Minimal Hepatic Encephalopathy;   Cirrhosis
Interventions: Procedure: Vastus Muscle Biopsy;   Drug: LOLA or placebo;   Other: Cognitive assessment (PHES);   Other: Cognitive Assessement (Cogstate);   Other: blood and urine sampling;   Other: Nutritional assessment;   Other: MRI brain and spectroscopy;   Other: MRI leg cross section;   Other: Functional MRI (working memory and attention tasks)
33 Not yet recruiting Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Drug: Flumazenil;   Drug: Placebo
34 Unknown  Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Intervention: Dietary Supplement: whole milk vs lactose-free milk
35 Unknown  Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate and lactulose;   Drug: placebo and lactulose
36 Recruiting Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy.
Intervention: Drug: Rifaximin-α
37 Unknown  The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hepatitis C;   Liver Cirrhosis
Intervention: Drug: Rifaximin (drug)
38 Unknown  A Nutritional Approach to Minimal Hepatic Encephalopathy
Condition: Minimal Hepatic Encephalopathy
Interventions: Other: Nutritional Intervention;   Other: Nutritional  Intervention
39 Unknown  RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin alone, Rifaximin combined with Lactulose
40 Not yet recruiting ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study
Condition: Hepatic Encephalopathy
Intervention: Dietary Supplement: probiotic VSL#3

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years